WallStreetZenWallStreetZen

NASDAQ: GEHC
Ge Healthcare Technologies Inc Stock

$82.64+2.45 (+3.06%)
Updated Jul 16, 2024
GEHC Price
$82.64
Fair Value Price
$64.60
Market Cap
$37.72B
52 Week Low
$62.35
52 Week High
$94.50
P/E
23.88x
P/B
5.09x
P/S
2.13x
PEG
1.52x
Dividend Yield
0.04%
Revenue
$19.50B
Earnings
$1.57B
Gross Margin
40.7%
Operating Margin
14.37%
Profit Margin
8.1%
Debt to Equity
3.32
Operating Cash Flow
$2B
Beta
1.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GEHC Overview

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Zen Score

Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GEHC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GEHC ($82.64) is overvalued by 27.92% relative to our estimate of its Fair Value price of $64.60 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
GEHC ($82.64) is not significantly undervalued (27.92%) relative to our estimate of its Fair Value price of $64.60 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GEHC ($82.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more GEHC due diligence checks available for Premium users.

Be the first to know about important GEHC news, forecast changes, insider trades & much more!

GEHC News

Valuation

GEHC fair value

Fair Value of GEHC stock based on Discounted Cash Flow (DCF)
Price
$82.64
Fair Value
$63.80
Overvalued by
29.53%
GEHC ($82.64) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GEHC ($82.64) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GEHC ($82.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GEHC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
23.88x
Industry
-0.26x
Market
31.71x
GEHC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GEHC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

GEHC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.09x
Industry
3.05x
GEHC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GEHC price to earnings growth (PEG)

For valuing profitable companies with growth potential
GEHC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

GEHC's financial health

Profit margin

Revenue
$4.7B
Net Income
$374.0M
Profit Margin
8%
GEHC's Earnings (EBIT) of $2.80B... subscribe to Premium to read more.
Interest Coverage Financials
GEHC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$32.2B
Liabilities
$24.6B
Debt to equity
3.32
GEHC's short-term assets ($9.37B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GEHC's long-term liabilities ($15.75B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GEHC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$419.0M
Investing
-$188.0M
Financing
-$153.0M
GEHC's operating cash flow ($2.05B)... subscribe to Premium to read more.
Debt Coverage Financials

GEHC vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
GEHC$37.72B+3.06%23.88x5.09x
VEEV$30.25B+0.76%54.25x6.19x
SOLV$8.64B+3.77%N/A2.24x
HQY$7.09B+5.68%87.57x3.38x
RCM$5.49B+1.88%-186.14x1.94x

Ge Healthcare Technologies Stock FAQ

What is Ge Healthcare Technologies's quote symbol?

(NASDAQ: GEHC) Ge Healthcare Technologies trades on the NASDAQ under the ticker symbol GEHC. Ge Healthcare Technologies stock quotes can also be displayed as NASDAQ: GEHC.

If you're new to stock investing, here's how to buy Ge Healthcare Technologies stock.

What is the 52 week high and low for Ge Healthcare Technologies (NASDAQ: GEHC)?

(NASDAQ: GEHC) Ge Healthcare Technologies's 52-week high was $94.50, and its 52-week low was $62.35. It is currently -12.55% from its 52-week high and 32.54% from its 52-week low.

How much is Ge Healthcare Technologies stock worth today?

(NASDAQ: GEHC) Ge Healthcare Technologies currently has 456,465,369 outstanding shares. With Ge Healthcare Technologies stock trading at $82.64 per share, the total value of Ge Healthcare Technologies stock (market capitalization) is $37.72B.

Ge Healthcare Technologies stock was originally listed at a price of $60.49 in Jan 4, 2023. If you had invested in Ge Healthcare Technologies stock at $60.49, your return over the last 1 years would have been 36.62%, for an annualized return of 36.62% (not including any dividends or dividend reinvestments).

How much is Ge Healthcare Technologies's stock price per share?

(NASDAQ: GEHC) Ge Healthcare Technologies stock price per share is $82.64 today (as of Jul 16, 2024).

What is Ge Healthcare Technologies's Market Cap?

(NASDAQ: GEHC) Ge Healthcare Technologies's market cap is $37.72B, as of Jul 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ge Healthcare Technologies's market cap is calculated by multiplying GEHC's current stock price of $82.64 by GEHC's total outstanding shares of 456,465,369.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.